Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent hypertension and dyslipidemia remain unknown. In...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Lin, Chia‐Pin, Tung, Ying‐Chang, Hsiao, Fu‐Chih, Yang, Chia‐Hung, Kao, Yi‐Wei, Lin, Yu‐Sheng, Chu, You‐Chia, Chu, Pao‐Hsien
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Combination Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029959/
https://ncbi.nlm.nih.gov/pubmed/32862551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars